150 related articles for article (PubMed ID: 21697498)
1. APOBEC3 has not left an evolutionary footprint on the HIV-1 genome.
Ebrahimi D; Anwar F; Davenport MP
J Virol; 2011 Sep; 85(17):9139-46. PubMed ID: 21697498
[TBL] [Abstract][Full Text] [Related]
2. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
Jern P; Russell RA; Pathak VK; Coffin JM
PLoS Pathog; 2009 Apr; 5(4):e1000367. PubMed ID: 19343218
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome.
Ebrahimi D; Anwar F; Davenport MP
Retrovirology; 2012 Dec; 9():113. PubMed ID: 23256516
[TBL] [Abstract][Full Text] [Related]
4. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
5. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
Miller JH; Presnyak V; Smith HC
Retrovirology; 2007 Nov; 4():81. PubMed ID: 18036235
[TBL] [Abstract][Full Text] [Related]
6. Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G.
Cen S; Peng ZG; Li XY; Li ZR; Ma J; Wang YM; Fan B; You XF; Wang YP; Liu F; Shao RG; Zhao LX; Yu L; Jiang JD
J Biol Chem; 2010 May; 285(22):16546-52. PubMed ID: 20363737
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the two cytidine deaminase domains in APOBEC3G.
Li X; Ma J; Zhang Q; Zhou J; Yin X; Zhai C; You X; Yu L; Guo F; Zhao L; Li Z; Zeng Y; Cen S
Virology; 2011 Jun; 414(2):130-6. PubMed ID: 21489586
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.
Bennett RP; Presnyak V; Wedekind JE; Smith HC
J Biol Chem; 2008 Mar; 283(12):7320-7. PubMed ID: 18165230
[TBL] [Abstract][Full Text] [Related]
9. Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
Zhang L; Saadatmand J; Li X; Guo F; Niu M; Jiang J; Kleiman L; Cen S
Virology; 2008 Jan; 370(1):113-21. PubMed ID: 17916373
[TBL] [Abstract][Full Text] [Related]
10. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S; Mercenne G; Bernacchi S; Paillart JC; Marquet R
Microbiol Mol Biol Rev; 2009 Jun; 73(2):211-32. PubMed ID: 19487726
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
12. Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.
Rulli SJ; Mirro J; Hill SA; Lloyd P; Gorelick RJ; Coffin JM; Derse D; Rein A
J Virol; 2008 Jul; 82(13):6566-75. PubMed ID: 18448535
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation.
Ma L; Zhang Z; Liu Z; Pan Q; Wang J; Li X; Guo F; Liang C; Hu L; Zhou J; Cen S
Sci Rep; 2018 May; 8(1):8067. PubMed ID: 29795228
[TBL] [Abstract][Full Text] [Related]
14. Footprint of APOBEC3 on the genome of human retroelements.
Anwar F; Davenport MP; Ebrahimi D
J Virol; 2013 Jul; 87(14):8195-204. PubMed ID: 23698293
[TBL] [Abstract][Full Text] [Related]
15. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
Poulain F; Lejeune N; Willemart K; Gillet NA
PLoS Pathog; 2020 Aug; 16(8):e1008718. PubMed ID: 32797103
[TBL] [Abstract][Full Text] [Related]
16. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
Armitage AE; Katzourakis A; de Oliveira T; Welch JJ; Belshaw R; Bishop KN; Kramer B; McMichael AJ; Rambaut A; Iversen AK
J Virol; 2008 Sep; 82(17):8743-61. PubMed ID: 18562517
[TBL] [Abstract][Full Text] [Related]
17. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
18. Insights into the motif preference of APOBEC3 enzymes.
Ebrahimi D; Alinejad-Rokny H; Davenport MP
PLoS One; 2014; 9(1):e87679. PubMed ID: 24498164
[TBL] [Abstract][Full Text] [Related]
19. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
20. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.
Ulenga NK; Sarr AD; Thakore-Meloni S; Sankalé JL; Eisen G; Kanki PJ
J Infect Dis; 2008 Aug; 198(4):486-92. PubMed ID: 18598197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
